The 2022 Annual Meeting today opened with over 700 international participants on-site and an additional livestream audience, totaling close to 1,000 attendees.
Read More
The advanced registration deadline for the CIMT Annual Meeting has been extended through March 13, midnight (CET).
Read MoreThe 2022 abstract submission deadline for the CIMT Annual Meeting has been extended through March 13, midnight (CET).
Read MoreThe CIMT program committee is calling for abstract submission through March 4, 2022.
Read MoreFrom cutting-edge basic research to the latest translational applications, the 2022 CIMT Annual Meeting will again cover the latest advances in the field. Stay tuned for more information to be posted in January.
Read MoreThe Association for Cancer Immunotherapy is saddened about the sudden loss of Dr. Martin “Mac” Cheever. Cheever was a pioneer of bone marrow transplants at the Fred Hutchinson Cancer Research Center.
Read MoreWe congratulate CIMT President Özlem Türeci who together with Katalin Karikó and Uğur Şahin will receive the Paul Ehrlich and Ludwig Darmstaedter Prize 2022. The award recognizes their contribution to the mRNA technology, on which the COVID-19 vaccine manufactured by BioNTech is based.
Read MoreThe 2022 CIMT Annual Meeting will take place May 10-12, 2022. More information will be provided as it becomes available.
Read MoreOn June 2, CIMT members gathered online for the 2021 CIMT general assembly and re-elected board members Prof. Carl Figdor and Prof. Kees Melief.
Read More